India’s obesity drug market is booming, poised for significant growth driven by rising lifestyle diseases and upcoming affordable generics. Experts anticipate wider access to GLP-1 medicines, accelerating innovation through AI, and a shift towards complex generics. This transformative phase promises improved patient outcomes and positions India as a key player in global healthcare advancements.
Weight-loss therapy set to push pharma growth
You May Also Like
Posted in
All
Spin Luck with Hot and Cold Slots – Win Big Tonight!
Posted by
Samreen Aslam
Posted in
All
Plinko Juego de Azar Clásico Español
Posted by
Samreen Aslam
Posted in
All
A Random Path to a Big Win in the Plinko Game
Posted by
Samreen Aslam